754
Views
19
CrossRef citations to date
0
Altmetric
Research Paper

Mechanisms underlying the induction of the putative human tumor suppressor GPRC5A by Retinoic acid

Pages 951-962 | Published online: 15 May 2009
 

Abstract

Retinoic acid regulates the expression of genes involved in cell proliferation,

differentiation, and survival by direct control of gene transcription via activation of

nuclear retinoid receptors bound to response elements in the promoters of target genes

or by indirect mechanisms. Herein, we investigated the mechanism by which retinoic

acid induces the expression of the human tumor suppressor GPRC5A. The proximal 5’

upstream region of the GPRC5A gene was found to contain two potential RAR/RXR

binding sites (RAREs) and one VDR/RXR binding site with direct repeat 5 (DR5) motifs

designated DR5I (-489 to -473), DR5II (-136 to -120), and DR5III (-81 to -65). DR5II and

DR5III but not DR5I were conserved among vertebrates. However, only DR5III (5’-

TGTCCCTCTGCTCACCC-3’) was found to be the functional RARE for mediating

induction of GPRC5A as indicated by electrophoretic mobility shift assay using wild type

and mutated synthetic oligonucleotides representing different fragments of the promoter

for competition with retinoic acid receptor β RARE. Chromatin immunoprecipitation

assay confirmed the binding of retinoic acid receptors α and γ and retinoid X receptors α

and β to DR5III in intact cells. These results demonstrate the importance of functional

analysis for validating the activity of predicted response elements.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.